Astrazeneca Phar

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE203A01020
  • NSEID: ASTRAZEN
  • BSEID: 506820
INR
8,105.95
-82.2 (-1.0%)
BSENSE

Aug 10

BSE+NSE Vol: 49.24 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 777011,
    "name": "Astrazeneca Phar",
    "stock_name": "Astrazeneca Phar",
    "full_name": "Astrazeneca Pharma India Ltd",
    "name_url": "stocks-analysis/astrazeneca-phar",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "8,105.95",
    "chg": -82.2,
    "chgp": "-1.0%",
    "dir": -1,
    "prev_price": "8,188.15",
    "mcapval": "20,551.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 506820,
    "symbol": "ASTRAZEN",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE203A01020",
    "curr_date": "Aug 10",
    "curr_time": "",
    "bse_nse_vol": "49.24 k",
    "exc_status": "Active",
    "traded_date": "Aug 10, 2026",
    "traded_date_str": "2026 08 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/astrazeneca-phar-777011-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "MN",
      "url": "https://marketsmojo.motilaloswal.com/mojopro/strategy/2",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/astrazeneca-phar-777011-0&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Astrazeneca Pharma India standalone net profit declines 32.06% in the June 2026 quarter",
        "link": "https://news.google.com/rss/articles/CBMi_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?oc=5",
        "imagepath": "",
        "date": "2026-08-10 17:04:29",
        "description": "Astrazeneca Pharma India standalone net profit declines 32.06% in the June 2026 quarter  business-standard.com..."
      },
      {
        "title": "AstraZeneca Pharma India Q1 profit drops to 37.93 crore",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-08-10 15:06:23",
        "description": "AstraZeneca Pharma India Q1 profit drops to 37.93 crore  BusinessLine..."
      },
      {
        "title": "AstraZeneca Pharma India Q1 results: Profit drops 32% to 37.93 crore",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-08-10 14:52:34",
        "description": "AstraZeneca Pharma India Q1 results: Profit drops 32% to 37.93 crore  business-standard.com..."
      },
      {
        "title": "AstraZeneca Shares Fall on Deal Talks With Bristol-Myers",
        "link": "https://news.google.com/rss/articles/CBMiswFBVV95cUxOekUxdXJYYUl4bFFHblEyWlVhWDZlcWNWUVI4VHd2b004ZUpzMHRYSHdkaUQ2TlZOdjRNTVBUaWNxeGkwYVREeDFDOEg0OWplVHlsSUR2VlNxTm9LWURkb2l6OWNUTXE2N3FfZHZQQ2RVQjk1MzBDTFZnU3FCLVg2QWU3ZHdhYk1BNlRiLVVCOExWbEdHZ0JOT3dheTJULWtlSU5iV3NUbWhiTFhFdVhJSE9zMA?oc=5",
        "imagepath": "",
        "date": "2026-08-03 13:38:23",
        "description": "AstraZeneca Shares Fall on Deal Talks With Bristol-Myers  Bloomberg<br>AstraZeneca slides after report of Bristol Myers merger talks leaves analysts \\'perplexed\\'  CNBC<br>An AstraZeneca, Bristol Myers Squibb merger could create a cancer-drug giant, but analysts call it odd  MarketWatch<br>Editors Corner: Why an AstraZeneca-Bristol Myers Squibb merger is a bad idea  Fierce Pharma<br>Biotech Stocks Need A Shot In The Arm After Brutal July: Could AstraZeneca-Bristol Myers Megadeal Be The Cure?  Yahoo Finance<br>..."
      },
      {
        "title": "AstraZeneca Shares Drop After Reports of Bristol Myers Squibb Merger Talks",
        "link": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQekYwV1hCemJVVnJJa3BYa1k4ZjNjNURUSnhNYjE0TDNBRWhxTnEyVFVzM2hkQTQ1R1RQQzc3NmdJOXNqSHFkbVI1UnRYWThEeXc2eWpldUNOay1mMG1MQktFbW94aGZxajJjVEJsU2pJSUwzWFhTcDl2RjlzdnpmejQzNVVfV2JDRTZZa0o4UnFvZ1pyTng2NjNjdlY2c0cxcTJLN2JnakplU1Zkb0szQnl6VkdHekZJ?oc=5",
        "imagepath": "",
        "date": "2026-08-03 13:36:00",
        "description": "AstraZeneca Shares Drop After Reports of Bristol Myers Squibb Merger Talks  WSJ..."
      },
      {
        "title": "AstraZeneca Pharma India CFO Bhavana Agrawal resigns",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-07-21 11:31:11",
        "description": "AstraZeneca Pharma India CFO Bhavana Agrawal resigns  Business Standard..."
      },
      {
        "title": "AstraZeneca Pharma India announces resignation of CFO",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-07-21 10:17:16",
        "description": "AstraZeneca Pharma India announces resignation of CFO  Business Standard..."
      },
      {
        "title": "AstraZeneca Pharma India announces resignation of CFO",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-07-21 10:17:16",
        "description": "AstraZeneca Pharma India announces resignation of CFO  Business Standard..."
      },
      {
        "title": "AstraZeneca Pharma India gets CDSCO nod for additional Fasenra indication",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-07-16 18:16:47",
        "description": "AstraZeneca Pharma India gets CDSCO nod for additional Fasenra indication  Business Standard..."
      }
    ],
    "total": 9,
    "sid": "777011",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/astrazeneca-pharma-india-777011"
  },
  "announcements": [
    {
      "caption": "Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015",
      "datetime": "08-Aug-2026",
      "details": "Please find the enclosed letter of the Company as per the captioned subject for your reference.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company To Be Held On Monday August 10 2026",
      "datetime": "04-Aug-2026",
      "details": "Astrazeneca Pharma India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 inter alia to consider and approve This is to inform that a meeting of the Board of Directors of AstraZeneca Pharma India Limited will be held on Monday August 10 2026 inter alia to consider and approve the Un-audited Financial Results of the Company for the quarter ended June 30 2026. We also confirm that the Trading Window remains closed for all Designated Persons from June 16 2026 to August 12 2026 (both days inclusive) in terms of AstraZeneca Pharma India Limited - Code of Conduct for Prevention of Insider Trading framed under Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015.",
      "source": "BSE"
    },
    {
      "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "30-Jul-2026",
      "details": "Please find the enclosed document of the Company in relation to the captioned subject for your reference.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Astrazeneca Pharma India Ltd has declared <strong>1800%</strong> dividend, ex-date: 31 Jul 26",
          "dt": "2026-07-31",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Astrazeneca Pharma India Ltd has announced <strong>2:10</strong> stock split, ex-date: 15 Jun 06",
          "dt": "2006-06-15",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015

08-Aug-2026 | Source : BSE

Please find the enclosed letter of the Company as per the captioned subject for your reference.

Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company To Be Held On Monday August 10 2026

04-Aug-2026 | Source : BSE

Astrazeneca Pharma India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 inter alia to consider and approve This is to inform that a meeting of the Board of Directors of AstraZeneca Pharma India Limited will be held on Monday August 10 2026 inter alia to consider and approve the Un-audited Financial Results of the Company for the quarter ended June 30 2026. We also confirm that the Trading Window remains closed for all Designated Persons from June 16 2026 to August 12 2026 (both days inclusive) in terms of AstraZeneca Pharma India Limited - Code of Conduct for Prevention of Insider Trading framed under Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015.

Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

30-Jul-2026 | Source : BSE

Please find the enclosed document of the Company in relation to the captioned subject for your reference.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Astrazeneca Pharma India Ltd has declared 1800% dividend, ex-date: 31 Jul 26

stock-summary
SPLITS

Astrazeneca Pharma India Ltd has announced 2:10 stock split, ex-date: 15 Jun 06

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available